Blood eosinophil levels as a biomarker in COPD
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder and patients respond differently to treatment. Blood eosinophils are a potential biomarker to stratify patient subsets for COPD therapy. We reviewed the value of blood eosinophils in predicting exacerbation risk and response to...
Main Authors: | Brusselle, G, Pavord, I, Landis, S, Pascoe, S, Lettis, S, Morjaria, N, Barnes, N, Hilton, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2018
|
Similar Items
-
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018) -
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui SH, et al.
Published: (2018-11-01) -
The significance of eosinophilic inflammation in COPD
by: Cooper, C, et al.
Published: (2017) -
The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
by: Pascoe, S, et al.
Published: (2018) -
Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis
by: Pavord, I, et al.
Published: (2016)